StrategicFunding OnLume has secured non-dilutive funding and a recent $14.7M financing round from technology-focused funds and notable institutions, signaling strong investor interest and a potential roadmap for grant-worthy collaborations, pilot programs, or co-development deals with hospitals and research centers.

ClinicalExpansion With a focus on fluorescence image-guided surgery for both veterinary and human medicine, there is an opportunity to target early adopters in surgical centers and academic hospitals seeking advanced intraoperative imaging to differentiate their procedures and improve outcomes.

Leadership New leadership and board experience from Cambridge Investment Group and WARF involvement indicate credibility with health systems and research institutions, which can ease procurement cycles and foster partnerships for pilots and broader deployment.

ProductFit Small company size and existing tech stack centered on visualization and imaging suggest a need for scalable integration within OR workflows; potential sales angles include interoperability with current imaging suites, data capture for outcomes, and surgeon-friendly ergonomic design.

MarketPosition Recognition in Wisconsin Innovation awards and a clear path to commercialization point to early traction; target benchmarking opportunities with mid-market surgical device distributors and regional hospital networks to accelerate adoption and volume.